The ESMO Targeted Anticancer Therapies Congress 2021 will give you a glimpse of the future of targeted anticancer therapies, as the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development.
TAT 2021 will also offer excellent opportunities for the presentation and discussion of ongoing and completed phase 1 studies in a highly interactive setting.
The current programme provides reviews and reports of recent research findings on a broad range of molecular targets and targeted anticancer agents.
Stakeholders from academy and industry will meet with clinicians, researchers and regulators to enhance the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.
ESMO Head Office
Via Ginevra 4